{"id":"https://openalex.org/W4399687283","doi":"https://doi.org/10.2337/db24-747-p","title":"747-P: Insulin Therapy Deintensification with iGlarLixi (IDEAL) Randomized Controlled Trial\u2014CGM-Related Outcomes","display_name":"747-P: Insulin Therapy Deintensification with iGlarLixi (IDEAL) Randomized Controlled Trial\u2014CGM-Related Outcomes","publication_year":2024,"publication_date":"2024-06-14","ids":{"openalex":"https://openalex.org/W4399687283","doi":"https://doi.org/10.2337/db24-747-p"},"language":"en","primary_location":{"id":"doi:10.2337/db24-747-p","doi":"https://doi.org/10.2337/db24-747-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db24-747-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025245063","display_name":"Peter Novodvorsk\u00fd","orcid":"https://orcid.org/0000-0002-3292-7586","observed_orcids":["https://orcid.org/0000-0002-3292-7586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PETER NOVODVORSKY","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065565136","display_name":"Lenka Thieme","orcid":"https://orcid.org/0000-0002-3845-7490","observed_orcids":["https://orcid.org/0000-0002-3845-7490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LENKA THIEME","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039829905","display_name":"Ivana La\u0148kov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"IVANA LANKOVA","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"ALICA VESEL\u00c1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ALICA VESEL\u00c1","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075865025","display_name":"Emil Z\u00e1humensk\u00fd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"EMIL ZAHUMENSKY","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037491415","display_name":"Tom\u00e1\u0161 Edelsberger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TOMAS EDELSBERGER","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099133327","display_name":"Marie L\u00f6blov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARIE L\u00d6BLOV\u00c1","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036561787","display_name":"FILIP HRUB\u00dd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FILIP HRUB\u00dd","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079425940","display_name":"MILOS MRAZ","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MILOS MRAZ","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023584418","display_name":"Martin Haluz\u0131\u0301k","orcid":"https://orcid.org/0000-0002-0201-6888","observed_orcids":["https://orcid.org/0000-0002-0201-6888"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARTIN HALUZIK","raw_affiliation_strings":["N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N\u00e1chod, Czech Republic, Zl\u00edn, Czech Republic, Krnov, Czech Republic, Cesk\u00e9 Budejovice, Czech Republic, Prague, Czech Republic","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12308948,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8935999870300293,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8935999870300293,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.1005999967455864,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iglarlixi","display_name":"iGlarLixi","score":0.9750000238418579},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.6570000052452087},{"id":"https://openalex.org/keywords/insulin-degludec","display_name":"insulin degludec","score":0.5090000033378601},{"id":"https://openalex.org/keywords/insulin-aspart","display_name":"insulin aspart","score":0.5979999899864197},{"id":"https://openalex.org/keywords/continuous-glucose-monitoring","display_name":"continuous glucose monitoring","score":0.8920000195503235},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8320000171661377},{"id":"https://openalex.org/keywords/glycemic-variability","display_name":"glycemic variability","score":0.8009999990463257},{"id":"https://openalex.org/keywords/time-in-range","display_name":"time in range","score":0.8119999766349792},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.5270000100135803},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.7599999904632568},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6119999885559082},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.6669999957084656},{"id":"https://openalex.org/keywords/ideal-trial","display_name":"IDEAL trial","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7846506834030151},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7224652171134949},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6703575253486633},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5358608365058899},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36171919107437134}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db24-747-p","doi":"https://doi.org/10.2337/db24-747-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db24-747-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725","https://openalex.org/W2148612803"],"abstract_inverted_index":{"Introduction:":[0],"The":[1],"IDEAL":[2,57,130],"RCT":[3,65],"examined":[4],"the":[5,32,54,95,100,105,123,139,162,178,291,297],"efficacy":[6],"and":[7,23,43,85,98,230,272,319,358,360,367,437,458],"safety":[8],"of":[9,34,36,45,104,115,129,197,371],"MDI":[10,84,163,273,338,364],"de-intensification":[11,336],"into":[12,79,339],"once-daily":[13],"administered":[14],"iGlarLixi":[15,80,140,179,258,340],"in":[16,75,110,122,138,161,182,199,257,296,341,346,374],"people":[17],"with":[18,31,66,83,363],"type":[19],"2":[20,102,201,354],"diabetes":[21],"(PwT2D)":[22],"showed":[24,343],"that":[25],"it":[26],"provides":[27],"comparable":[28],"glycemic":[29],"control":[30],"benefits":[33],"reduction":[35],"body":[37],"weight,":[38],"total":[39],"daily":[40],"insulin":[41,46],"dose":[42],"number":[44],"injections.":[47],"Here":[48],"we":[49],"report":[50],"CGM":[51,89,116,299,347],"outcomes":[52,348],"from":[53,337],"trial.":[55],"Methods:":[56],"was":[58],"a":[59,67,76],"5-centre,":[60],"open-label,":[61],"parallel-group,":[62],"phase":[63],"4":[64],"24-week":[68],"active":[69],"treatment":[70,106],"period.":[71],"Participants":[72,109],"were":[73,86,118,120,132,247,304],"randomized":[74],"1:1":[77],"fashion":[78],"or":[81],"continuation":[82,362],"applied":[87],"professional":[88],"(Freestyle":[90],"Libre":[91],"Pro":[92],"iQ)":[93],"before":[94],"onset":[96],"(BL)":[97],"for":[99],"last":[101],"weeks":[103],"period":[107],"(W24).":[108],"whom":[111],"\u2265":[112],"72":[113],"hours":[114],"data":[117],"available":[119],"included":[121],"analysis.":[124],"Results:":[125],"Altogether":[126],"73/91":[127],"(80.2%)":[128],"participants":[131],"analyzed.":[133],"Median":[134,249],"(IQR)":[135,250],"%TIR":[136],"increased":[137],"group":[141,164,180,259,274],"(70":[142],"[57":[143],"-":[144,151,167,172,186,191,205,210,219,224,237,242,262,267,277,282,294,309,314,323,328],"88]":[145],"at":[146,153],"BL":[147],"vs":[148,169,188,207,221,239,264,279,302,311,325,349,361],"80":[149],"[61":[150],"92]":[152],"W24,":[154],"p":[155,174,193,212,227,244,269,284,316,330],"=":[156,175,194,213,228,245,270,285,317,331],"0.039),":[157],"but":[158],"remained":[159,255],"unchanged":[160,256],"(78":[165],"[67":[166],"89]":[168],"82":[170],"[64":[171],"89],":[173],"0.728).":[176],"In":[177],"reductions":[181],"%TAR":[183],"(26":[184,235],"[11":[185],"44]":[187],"13":[189],"[6":[190],"35],":[192,243],"0.04),":[195],"%":[196],"time":[198,372],"level":[200,353],"hyperglycemia":[202],"(2":[203],"[1":[204],"9]":[206],"1":[208,265,280],"[0":[209,261,266,276,281],"4],":[211],"0.019),":[214],"mean":[215,356],"glucose":[216,357],"(8.6":[217],"[7.4":[218],"10.1]":[220],"7.7":[222],"[6.9":[223],"9.2]":[225],"mmol/L,":[226],"0.012)":[229],"glycemia":[231],"risk":[232],"index":[233],"(GRI)":[234],"[10":[236],"46]":[238],"19":[240],"[8":[241],"0.036)":[246],"detected.":[248],"%TBR":[251],"(<":[252],"3.9":[253],"mmol/L)":[254],"(0":[260],"1]":[263],"2],":[268],"0.337)":[271],"(0.5":[275],"2]":[278],"3.75],":[283],"0.147).":[286],"Statistically":[287],"significant":[288],"differences":[289],"between":[290],"changes":[292],"(BL":[293],"W24)":[295],"following":[298],"metrics":[300],"(iGlarLixi":[301],"MDI)":[303],"observed:":[305],"%CV":[306],"(-0.8":[307],"[-3.4":[308],"0.75]":[310],"1.4":[312],"[-1.2":[313],"3.3],":[315],"0.016)":[318],"GRI":[320],"(-3.2":[321],"[-22.4":[322],"2.4]":[324],"1.6":[326],"[-6.25":[327],"10.6],":[329],"0.045).":[332],"Conclusion:":[333],"Insulin":[334],"therapy":[335],"PwT2D":[342],"an":[344],"improvement":[345],"baseline":[350],"(TIR,":[351],"TAR,":[352],"hyperglycemia,":[355],"GRI)":[359,368],"(glycemic":[365],"variability":[366],"without":[369],"increase":[370],"spent":[373],"hypoglycemia.":[375],"Disclosure":[376],"P.":[377],"Novodvorsky:":[378],"Speaker's":[379,386,394,474],"Bureau;":[380,387,395,475],"Sanofi,":[381,432,453,476],"Boehringer-Ingelheim.":[382,385],"Advisory":[383,430],"Panel;":[384,431],"Novo":[388,433,454,477],"Nordisk":[389],"A/S.":[390],"Research":[391,471],"Support;":[392,472],"Sanofi.":[393,473],"Abbott,":[396],"Medtronic,":[397],"Berlin-Chemie":[398],"AG,":[399],"Viatris":[400],"Inc.,":[401,441,452,462],"Novartis":[402],"AG.":[403],"L.":[404],"Thieme:":[405],"None.":[406,409,412,415,418,421,424,427],"I.":[407],"Lankova:":[408],"A.":[410],"Vesel\u00e1:":[411],"E.":[413],"Zahumensky:":[414],"T.":[416],"Edelsberger:":[417],"M.":[419,425,428],"L\u00f6blov\u00e1:":[420],"F.":[422],"Hrub\u00fd:":[423],"Mraz:":[426],"Haluzik:":[429],"Nordisk,":[434,455],"Eli":[435,456],"Lilly":[436,457],"Company,":[438,459],"AstraZeneca,":[439,460],"Bayer":[440,461],"Johnson":[442,444,464,466],"&":[443,450,465],"Medical":[445,467],"Devices":[446,468],"Companies.":[447],"Consultant;":[448],"Merck":[449],"Co.,":[451],"Boehringer-Ingelheim,":[463],"Companies,":[469],"Novatin.":[470],"Nordisk.":[478],"Funding":[479],"Sanofi":[480]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}